Gene and Cell Therapy – Products

Thermo Fisher opens its East Coast ATxCC in Philadelphia, expanding support for innovators developing next-generation cell and gene therapies.

UChicago and Terumo BCT achieve the first automated 3-in-1 TCR-T workflow on Quantum Flex, accelerating consistent cell therapy production.

TRANSCAN-3 advances personalized T-cell therapies for esophageal cancer with progress in neoantigen discovery and T-cell isolation.

ScaleReady awards Sonoma Biotherapeutics a $300,000 G-Rex^® Grant to accelerate Treg therapy manufacturing development.

Lonza acquires Redberry to expand bioscience testing with rapid, high-precision microbiology solutions for pharmaceutical quality control.

Lonza will acquire Redberry, adding its Red One^™ rapid microbiology platform to accelerate pharma QC testing and product release.

Aptamer inks £360K deal with a top pharma to develop Optimer® radiopharmaceuticals targeting cancer.

Adva and Autolomous launch the Digital PIONEER Program to scale and digitize cell therapy manufacturing with GenCART as first partner.

Multiply Labs and Thermo Fisher expand collaboration to integrate robotic platforms with automated cell therapy systems.

Waters launches Xevo CDMS, enabling direct, precise analysis of mega-mass biomolecules for next-gen therapies.